Open an account

Waters

WAT · NYSE

$442.83+$8.56 (+1.97%)TodayMarket closed ·
Prev close $434.27

About WAT

Waters Corp. engages in the provision of workflow solutions involving liquid chromatography, mass spectrometry, and thermal analysis. The company is headquartered in Milford, Massachusetts and currently employs 7,900 full-time employees. The firm offers analytical instruments, separations technologies, and software, serving life, materials, food, and environmental sciences. Its segments include Waters and TA. The firm primarily designs, manufactures, sells and services high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. The firm designs, manufactures, sells and services thermal analysis, rheometry and calorimetry instruments through its TA Instruments (TA) product line. The firm is also a developer and supplier of advanced software-based products that interface with the Company’s instruments, as well as other manufacturers’ instruments.

Employees
7,900
Headquarters
Milford, Massachusetts
Listed
Nov 17, 1995
Sector
Health Care
Industry
Life Sciences Tools & Services
Website
waters.com

WAT key statistics

Market cap
42.93B
Price-earnings ratio
108.57
Dividend yield
—
Average volume
842.80K
Volume
776.61K
Open price
$436.64
High today
$448.03
Low today
$427.97
52 Week high
$454.54
52 Week low
$282.77

Waters (WAT) at a glance

As of Oct 20, 2026, Waters (WAT) shares are priced at $442.83, giving the company a market cap of 42.93B and a price-to-earnings ratio of 108.57.

Today the stock has traded between $427.97 and $448.03. The current price is 3.5% above the day's low and 1.2% below its high.

Volume so far is 776.61K shares, in line with the average of 842.80K shares a day.

Over the past year Waters has ranged from $282.77 to $454.54, and now sits 93% of the way up that range.

Waters met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q2 FY26 it reported $3.05 per share against an estimate of $3.04.

The average analyst price target is $456.24, 3.0% above the current price, from 21 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

67%of 21 analyst ratings say Buy
  • Buy66.7%
  • Hold33.3%
  • Sell0.0%
Price target · 26 analystsAvg $456.24
Low
$355.22
Now
$442.83
High
$540.75

WAT earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 6 of the last 8 quarters, by 4.9% on average.

  1. Q3 FY24: reported $2.93 per share against an estimate of $2.71
  2. Q4 FY24: reported $4.10 per share against an estimate of $4.07
  3. Q1 FY25: reported $2.25 per share against an estimate of $2.24
  4. Q2 FY25: reported $2.95 per share against an estimate of $2.97
  5. Q3 FY25: reported $3.40 per share against an estimate of $3.24
  6. Q4 FY25: reported $4.53 per share against an estimate of $4.55
  7. Q1 FY26: reported $2.70 per share against an estimate of $2.36
  8. Q2 FY26: reported $3.05 per share against an estimate of $3.04

WAT news

  • Press releasePRNewswire

    Waters Corporation and Quest Diagnostics Help Close Cervical Cancer Screening Gap Bringing Nationwide Access to the Most Comprehensive FDA-Cleared At-Home HPV Screening Option

  • Press releaseBusiness Wire

    IMU and UK Biobank to generate the world’s most detailed, large-scale picture of the human immune system for advancing research into health and disease

  • Press releasePRNewswire

    Waters Launches AI Link, Advancing AI-Enabled LC-MS Workflows from Research to Release

  • Piero Cingari

    Nvidia, Micron and Other 5 S&P 500 Stocks With +100% Revenue Growth

  • Piero Cingari

    The S&P 500 Is Partying at Record Highs: Only 3% of Its Stocks Were Invited

  • Press releasePRNewswire

    Waters Corporation Schedules Third Quarter 2026 Earnings Conference Call

  • Press releasePRNewswire

    Waters Sets Benchmark for Standardized Spectral Flow Cytometry with Commercial Launch of BD FACSDiscover A7 Cell Analyzer

  • Press releasePRNewswire

    Waters Corporation to Present at the J.P. Morgan U.S. All Stars Conference

Similar companies

Companies in the same industry as Waters

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.